Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with

Boaz O Owuor1, Collins O Odhiambo, Walter O Otieno

  • 1The US Army Medical Research Unit, Kenya, and the Kenya Medical Research Institute, Nairobi, Kenya.

Insights

Children with severe malaria-associated anemia (SMA) show deficiencies in red blood cell complement regulatory proteins, impairing immune complex binding and increasing complement deposition. These findings highlight a potential mechanism for red blood cell damage in severe malaria.

Area of Science:

  • Immunology
  • Hematology
  • Infectious Diseases

Background:

  • Plasmodium falciparum malaria is a leading cause of mortality, particularly in children.
  • Severe malaria complications include severe anemia and cerebral malaria.
  • Red blood cells (erythrocytes) play a role in regulating complement activation and clearing immune complexes.

Purpose of the Study:

  • To investigate the functional consequences of deficiencies in red cell complement regulatory proteins in children with severe malaria-associated anemia (SMA).
  • To determine if these deficiencies affect immune complex binding and complement activation.
  • To compare these findings with children suffering from cerebral malaria (CM).

Main Methods:

  • Studied 75 children with SMA and 74 uncomplicated malaria controls from Kenya.
  • Recruited 32 children with CM and 52 controls.
  • Assessed red cell complement receptor 1 (CR1) and decay accelerating factor (DAF, CD55) levels, immune complex binding capacity, and C3b deposition.
  • Utilized in vivo and ex vivo analyses.

Main Results:

  • Children with SMA exhibited deficiencies in red cell CR1 and CD55.
  • These deficiencies correlated with a significant reduction in immune complex binding capacity.
  • Increased C3b deposition was observed in erythrocytes from children with SMA, indicating heightened complement activation.
  • These specific changes were not observed in children with cerebral malaria or their controls.

Conclusions:

  • Deficiencies in red cell CR1 and CD55 in children with SMA are functionally significant.
  • These deficiencies impair the erythrocytes' ability to bind immune complexes and regulate complement.
  • This may predispose erythrocytes to complement-mediated damage and phagocytosis, contributing to severe anemia in malaria.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...